Knowde Enhanced TDS
Identification & Functionality
- Ingredient Name
- Food Ingredients Functions
- Pharma & Nutraceuticals Functions
Features & Benefits
- Benefit Claims (Health)
- Food Ingredients Features
- Product Background
- Obesity, recognized as a chronic disease by WHO and the European Commission, poses a significant global health issue.
- By 2035, it is estimated that 1.9 billion people worldwide will be obese, with 1 in 4 individuals affected.
- In Taiwan, the overweight and obesity rate among adults has been on the rise, reaching 50.3%.
- Obesity is closely linked to various diseases, including type 2 diabetes, cardiovascular diseases, cancer, and more.
- Defining Obesity: WHO uses BMI (Body Mass Index) to measure obesity, with a BMI of 24 or higher considered obese.
- Microbiota-Gut-Brain Axis: Gut microbiota composition impacts the host's physical and psychological well-being, influenced by long-term dietary habits.
- High-fat and high-sugar foods can trigger inflammation through the microbiota-gut-brain axis, affecting brain function.
- Studies on mice showed changes in gut bacteria abundance when fed a high-fat diet, impacting neurotransmitter production with physiological effects on the host.
- Product Features
- Better efficacy
- Stronger immunity
- Shorter recovery time
- Function: Weight management
Applications & Uses
- Applications
- Food & Nutrition Applications
- Use Level
- 6.0 x 10¹⁰ CFU
- Solution for Weight Management
- Our R&D Center has selected PRONULIFE® FitStay probiotics: Bifidobacterium animalis subsp. infantis CP-9 and Lactobacillus rhamnosus bv-77.
- This formula reduces intestinal fat absorption, slows weight gain, and decreases heart fat accumulation. It addresses fatty liver and kidney function issues in obesity.
- Human experiments show it lowers body weight, blood lipid levels, and other obesity-related values.
Properties
- Contents
- Bifidobacterium animalis subsp. lactis CP-9
- Lactobacillus rhamnosus bv-77
Regulatory & Compliance
- Certifications & Compliance